Among macrovascular events, a highly significant reduction was observed for each specific clinical condition in the rapid-acting insulin analogue users.
← all excerpts
Lower rate of cardiovascular complications in patients on bolus insulin analogues: a retrospective population-based cohort study.
1
—
—